HCP
66
8
AA
48
-12
TROW
56
5
MAS
58
2
BK
74
2
ROP
62
3
BMY
60
2
BBY
46
10
BSX
67
-3
SYK
64
-4
STI
14
-17
HAS
33
3
TGT
22
2
R
71
4
XRAY
28
2
EMN
60
4
URBN
56
14
CSX
60
3
LNC
39
3
COF
60
2
HCP
66
8
AA
48
-12
TROW
56
5
MAS
58
2
BK
74
2
ROP
62
3
BMY
60
2
BBY
46
10
BSX
67
-3
SYK
64
-4
STI
14
-17
HAS
33
3
TGT
22
2
R
71
4
XRAY
28
2
EMN
60
4
URBN
56
14
CSX
60
3
LNC
39
3
COF
60
2
Financhill
Back

Exact Sciences 10K Form

Sell
27

EXAS
Exact Sciences

Last Price:
52.87
Seasonality Move:
14.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q EXAS/Exact Sciences Quarterly
2023-11-01 10Q EXAS/Exact Sciences Quarterly
2023-08-01 10Q EXAS/Exact Sciences Quarterly
2023-05-09 10Q EXAS/Exact Sciences Quarterly
2022-11-03 10Q EXAS/Exact Sciences Quarterly
2022-08-02 10Q EXAS/Exact Sciences Quarterly

Receive EXAS News And Ratings

See the #1 stock for the next 7 days that we like better than EXAS

EXAS Financial Statistics

Sales & Book Value

Annual Sales: $2.5B
Cash Flow: $112.56M
Price / Cash Flow: 98.45
Annual Sales: $17.35
Price / Book: 3.05

Profitability

EPS (TTM): -1.17000
Net Income (TTM): $-214.04M
Gross Margin: $1.85B
Return on Equity: -6.77%
Return on Assets: -3.27%

Exact Sciences Earnings Forecast

Key Exact Sciences Financial Ratios

  • The Gross Profit Margin over the past 26 years for EXAS is 73.83%.
  • The Selling, General & Administrative Expenses for EXAS have been equal to 64.82% of Gross Profit Margin.
  • The Research & Development expenses have been 17.04% of Revenue.
  • The Interest Expense is -11.96% of Operating Income.
  • The Net Earning history of EXAS is -8.17% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 14 years.

Exact Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EXAS
CUSIP: 30063P
Website: exactsciences.com

Debt

Debt-to-Equity Ratio: 0.8
Current Ratio: 2.12
Quick Ratio: 1.78

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EXAS Technical Analysis vs Fundamental Analysis

Sell
27
Exact Sciences (EXAS) is a Sell

Is Exact Sciences a Buy or a Sell?

  • Exact Sciences stock is rated a Sell
    The current Exact Sciences [EXAS] share price is $52.91. The Score for EXAS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.